eHealth CEO Fran Soistman extends term to Sept 30, 2025; receives $1M retention award

eHealth, Inc.

CEO Soistman will stay as CEO until successor appointed or Sept 30, 2025, then serve as Executive Advisor through Dec 31, 2025.
Soistman receives $1M retention cash award (payable Jan 2026) and 2025 performance bonus; no separate annual equity or bonus.
Soistman acknowledges no severance on transition; will continue vesting of existing equity.
Stockholders approved amending 2024 Equity Incentive Plan to add 1.5M shares for future grants.
Directors Hass, Soistman, Tolson re-elected; EY ratified as auditor; say-on-pay approved.

item 5.02 item 5.07 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Fran Soistman

executive advisor

EHTH · eHealth, Inc.

Filed: June 24, 2025, 7:59 PM ET

Mr. Soistman has agreed to continue serving as chief executive officer and all other roles with its subsidiaries through the earlier of (i) the effective date of the appointment of his successor as chief executive officer or (ii) September 30, 2025 (the “CEO Transition” and such period, the “Additional CEO Period”), and following the CEO Transition, to assume the role of executive advisor until December 31, 2025 to assist with the transition to a new chief executive officer (the “Transition Period”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Fran Soistman changed role as executive advisor at eHealth, Inc..

Action: agreed to continue serving as chief executive officer and subsequently assume the role of executive advisor
Role: executive advisor

Exact text from the filing

Mr. Soistman has agreed to continue serving as chief executive officer and all other roles with its subsidiaries through the earlier of (i) the effective date of the appointment of his successor as chief executive officer or (ii) September 30, 2025 (the “CEO Transition” and such period, the “Additional CEO Period”), and following the CEO Transition, to assume the role of executive advisor until December 31, 2025 to assist with the transition to a new chief executive officer (the “Transition Period”).

View on SEC.gov

eHealth, Inc. filing history →

Source: SEC EDGAR

accession 0001333493-25-000078

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.